• Happy Holidays from AcceGen! Orders placed during Dec 22–Jan 2 will be processed and shipped after operations resume. Please plan ahead.

Primary Cells

Human Idiopathic Pulmonary Fibrosis (IPF) Peripheral Blood Mononuclear Cells

  • For research use only

Cat No.

ABC-TC4364

Product Type

Diseased Human Peripheral Blood Mononuclear Cells

Cell Type

Mononuclear Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Idiopathic Pulmonary Fibrosis

Storage

Liquid Nitrogen

Explore Human Idiopathic Pulmonary Fibrosis PBMCs for studying immune dysregulation, fibrosis progression, and chronic lung disease biomarker discovery.

Product Image

Description

Human Idiopathic Pulmonary Fibrosis (IPF) Peripheral Blood Mononuclear Cells are immune cells isolated from the peripheral blood of Idiopathic Pulmonary Fibrosis (IPF) patients, primarily comprising lymphocytes (T cells, B cells, NK cells) and monocytes. These cells play key roles in immune regulation, inflammation, and fibrosis progression in IPF. Monocytes differentiate into profibrotic macrophages, secreting TGF-β and PDGF to activate fibroblasts, while aberrant T-cell responses exacerbate collagen deposition. IPF-PBMCs are linked to chronic inflammation, aberrant wound healing, and progressive lung scarring, with altered cytokine profiles (elevated IL-4, IL-13, IL-17A) contributing to disease pathogenesis.

Species

Human

Cat.No

ABC-TC4364

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Product Category Primary Cells
Size/Quantity

1 vial

Cell Type

Mononuclear Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Idiopathic Pulmonary Fibrosis

Storage

Liquid Nitrogen

Product Type

Diseased Human Peripheral Blood Mononuclear Cells

Application

  • Human Idiopathic Pulmonary Fibrosis (IPF) Peripheral Blood Mononuclear Cells can be used to study the immune pathogenesis of IPF. These cells can also be used to evaluate the immunomodulatory effects of existing anti-fibrotic drugs (such as nintedanib and pirfenidone), and to screen new therapeutic drugs targeting specific inflammatory pathways.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Idiopathic Pulmonary Fibrosis (IPF) Peripheral Blood Mononuclear Cells

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button